Meeting
2018 ASCO Annual Meeting
Randomized, open-label, phase 3 study of subcutaneous daratumumab (DARA SC) versus active monitoring in patients (Pts) with high-risk smoldering multiple myeloma (SMM): AQUILA.
Authors
S.Vincent Rajkumar
Division of Hematology, Mayo Clinic, Rochester, MN
S.Vincent Rajkumar , Peter Michael Voorhees , Hartmut Goldschmidt , Ross I. Baker , Rajesh Bandekar , Steven Kuppens , Tobias Neff , Ming Qi , Meletios A. Dimopoulos
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Hematologic Malignancies—Plasma Cell Dyscrasia
Track
Hematologic Malignancies—Plasma Cell Dyscrasia
Sub Track
Plasma Cell Disorders
Clinical Trial Registration Number
NCT03301220
Citation
J Clin Oncol 36, 2018 (suppl; abstr TPS8062)
DOI
10.1200/JCO.2018.36.15_suppl.TPS8062
Abstract #
TPS8062
Poster Bd #
68b
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Subcutaneous daratumumab (DARA SC) versus active monitoring in patients (pts) with high-risk smoldering multiple myeloma (SMM): Randomized, open-label, phase 3 AQUILA study.
First Author: Meletios A. Dimopoulos
Poster
2020 ASCO Virtual Scientific Program
Corticosteriod tapering in patients (Pts) with relapsed or refractory multiple myeloma (RRMM) receiving subcutaneous daratumumab (DARA SC): Part 3 of the open-label, multicenter, phase Ib PAVO Study.
First Author: Hareth Nahi
Poster
2018 ASCO Annual Meeting
Randomized, open-label, non-inferiority, phase 3 study of subcutaneous (SC) versus intravenous (IV) daratumumab (DARA) administration in patients with relapsed or refractory multiple myeloma (RRMM): COLUMBA.
First Author: Saad Zafar Usmani
Poster
2018 ASCO Annual Meeting
Subcutaneous daratumumab (DARA) in patients (Pts) with relapsed or refractory multiple myeloma (RRMM): Part 2 update of the open-label, multicenter, dose escalation phase 1b study (PAVO).
First Author: Ajai Chari